CLRPF (Clarity Pharmaceuticals) FFO


CLRPF Clarity Pharmaceuticals Ltd CLRPF
34 GF Score
Price $1.48
! 2 Warning Signs
View Full Analysis

What is Clarity Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

CLRPF
34GF Score
Clarity Pharmaceuticals Ltd CLRPF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clarity Pharmaceuticals Business Description

Other Exchanges 1F4:GermanyCU6:Australia
Address 2-4 Cornwallis Street, Suite 212a, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, using its SAR Technology platform. Clarity's Targeted Copper Theranostic (TCT) platform of products utilize pairing of copper isotopes, specifically copper-64 (Cu-64 or 64Cu) for imaging and copper-67 Cu-67 or 67Cu) for therapy, which delivers accuracy and precision in the treatment of a range of cancers. The company's clinical development pipeline includes SAR-bisPSMA, SAR-Bombesin, and Sartate, in their different stages of development for the diagnosis and/or treatment of various cancers. Clarity operates in a single segment, which is the development of radiopharmaceuticals. Geographically, it operates in Australia and the United States.
34GF Score

Get the complete analysis for CLRPF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.48
Price